Avivagen (OTCMKTS:VIVXF) (TSXV:VIV) Stock Continues to Trade in a Narrow Range
Shares of Avivagen (OTCMKTS:VIVXF) (TSXV:VIV) have been moving within a narrow range.
Market Stats
On Wednesday, VIVXF stock ended flat at $0.2350 with more than 1 shares, compared to its average volume of 5k shares. The stock has moved within a range of $0.2350 – 0.2350 after opening trading at $0.2350.
Avivagen Announces CEO Update to Shareholders
Life sciences company focusing on developing and commercializing products for livestock, animal, and human applications, Avivagen (OTCMKTS:VIVXF) (TSXV:VIV), announced on January 26, 2022, updates to shareholders.
In the update, the CEO highlighted that the previous year had significant challenges as global feed production also suffering. The company has to suffer from higher input costs, supply chain challenges, as well as producers, experiencing financial difficulties and retrenchment.
The letter accentuates that the environment is becoming better and Avivagen is looking to ramp up activities in this year.
Purchase of OxC-beta Livestock is expected to increase, reaching volumes in line with expectations. The CEO added that the continued progress with regulatory processes and trials as well as discussions with potential distribution partners is moving ahead.
The firm is looking at building a team that would be conducive for the future and recently appointed Jamie Nickerson as the President. A core member of the company for 15 years, Jamie has become the main contact with several important relationships and developing new products. The firm also confirmed on establishing vital new relationships through Mexico-based partner, Meyenberg International Group, which would facilitate expansion efforts in Central and South America.
A recently published piece in the international medical journal, Lancet, had said that antibiotic resistance kills over a million every year, entailing the need for sustainable and safe alternatives to antibiotics.
Traders Corner
VIVXF stock is trading below the 10-Day and 50-Day Moving averages of $0.2350 and $0.2544 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.3112.
